Search research articles
Contact Us
Filters
Showing results (151-160 of 172) with videos related to
Page
of 18
Sort By:
Vaccine
|
July 29, 2017
Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial
Mark J Mulligan, Jack T Stapleton, Wendy A Keitel, et al.
Human Vaccines & Immunotherapeutics
|
September 12, 2024
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
Nginache Nampota-Nkomba, Osward M Nyirenda, Victoria Mapemba, et al.
The Journal of Infectious Diseases
|
March 26, 2026
Safety and Immunogenicity of a Trivalent Salmonella Conjugate Vaccine to S. Typhi, S. Typhimurium, and S. Enteritidis
Wilbur H Chen, Charmagne G Beckett, Mohamed Al-Ibrahim, et al.
The Lancet. Global Health
|
August 12, 2022
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial
Nginache Nampota-Nkomba, Osward M Nyirenda, Lameck Khonde, et al.
Journal of Medical Virology
|
March 14, 2023
Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS-CoV-2
Hyung J Kwon, Jun Zhang, Matina Kosikova, et al.
Iscience
|
November 14, 2022
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
Hyung-Joon Kwon, Martina Kosikova, Weichun Tang, et al.
Vaccine
|
December 27, 2025
Maternal iron status and total immunoglobulin-G influence transplacental antibody transfer across eight diverse geographical settings
Karen S Tiley, Hinke Ten Hulscher-van Overbeek, Andrew E Armitage, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 3, 2021
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
Sodiomon B Sirima, Alphonse Ouedraogo, Nouhoun Barry, et al.
Nature Medicine
|
October 8, 2025
A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial
Wilbur H Chen, Robin S Barnes, Michael J Sikorski, et al.
Clinical and Vaccine Immunology : CVI
|
October 13, 2017
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
Samba O Sow, Milagritos D Tapia, Wilbur H Chen, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 172) with videos related to
Sort By:
Page
of 18
Vaccine
|
July 29, 2017
Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial
Mark J Mulligan, Jack T Stapleton, Wendy A Keitel, et al.
Human Vaccines & Immunotherapeutics
|
September 12, 2024
Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children
Nginache Nampota-Nkomba, Osward M Nyirenda, Victoria Mapemba, et al.
The Journal of Infectious Diseases
|
March 26, 2026
Safety and Immunogenicity of a Trivalent Salmonella Conjugate Vaccine to S. Typhi, S. Typhimurium, and S. Enteritidis
Wilbur H Chen, Charmagne G Beckett, Mohamed Al-Ibrahim, et al.
The Lancet. Global Health
|
August 12, 2022
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial
Nginache Nampota-Nkomba, Osward M Nyirenda, Lameck Khonde, et al.
Journal of Medical Virology
|
March 14, 2023
Distinct in vitro and in vivo neutralization profiles of monoclonal antibodies elicited by the receptor binding domain of the ancestral SARS-CoV-2
Hyung J Kwon, Jun Zhang, Matina Kosikova, et al.
Iscience
|
November 14, 2022
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond
Hyung-Joon Kwon, Martina Kosikova, Weichun Tang, et al.
Vaccine
|
December 27, 2025
Maternal iron status and total immunoglobulin-G influence transplacental antibody transfer across eight diverse geographical settings
Karen S Tiley, Hinke Ten Hulscher-van Overbeek, Andrew E Armitage, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 3, 2021
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: A randomized controlled phase 2 trial
Sodiomon B Sirima, Alphonse Ouedraogo, Nouhoun Barry, et al.
Nature Medicine
|
October 8, 2025
A combination typhoid and non-typhoidal Salmonella polysaccharide conjugate vaccine in healthy adults: a randomized, placebo-controlled phase 1 trial
Wilbur H Chen, Robin S Barnes, Michael J Sikorski, et al.
Clinical and Vaccine Immunology : CVI
|
October 13, 2017
Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial Comparing the Reactogenicity and Immunogenicity of a Single Standard Dose to Those of a High Dose of CVD 103-HgR Live Attenuated Oral Cholera Vaccine, with Shanchol Inactivated Oral Vaccine as an Open-Label Immunologic Comparator
Samba O Sow, Milagritos D Tapia, Wilbur H Chen, et al.
Page
of 18